Progeria — A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Citation(s)
A Phase II Pilot Study of Zoledronic Acid, Pravastatin, and Lonafarnib (SCH66336) for Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) and Progeroid Laminopathies